Brief: Heidelberg Pharma Main Shareholder Dievini Commits To Further Financing
July 21 (Reuters) - HEIDELBERG PHARMA AG HPHA.DE :
* MAIN SHAREHOLDER DIEVINI COMMITS TO FURTHER FINANCING FOR
EXPANSION OF PROPRIETARY PIPELINE
* DIEVINI HOPP BIOTECH HOLDING GMBH & CO. KG, WALLDORF,
GERMANY,
WILL PROVIDE COMPANY WITH UP TO EUR 15 MILLION
* FINANCIAL COMMITMENT WILL MAINTAIN FINANCING REACH UNTIL
MID-2021
Source text for Eikon: ID:nEQ6wNHBfa
Further company coverage: HPHA.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty